Market data not licensed for redistribution.
Samsung Biologics – Insider holding report
207940 · KOSPI · Filed 2026-10-30 KST · 임원ㆍ주요주주특정증권등소유상황보고서
The key numbers, in plain words Insider holding report
- 김기중 (executive) reduced by 2 shares; now holds 55 shares (0.00% of the company).
- Officers and 10%+ holders must report changes within 5 business days; a report alone is not a signal of intent.
From the filing and DART structured data. Facts only, not advice; the Korean original prevails.
History for this filing type
After 23,869 similar filings (Insider / major-holder ownership report), the stock did better than the market the next day 48% of the time (avg +0.0% vs. the market). Past results, not a prediction. Reaction stats
All key numbers (as filed)
| holder ko | 김기중 |
| role | executive director |
| role ko | 상무 |
| shares | 55 |
| shares change | -2 |
| pct | 0 |
| pct change | 0 |
Korean original on DART: DART 20261030000685
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer → Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
© Crypvu · Crypto market view
Market data not licensed for redistribution.
© Crypvu · Crypto market view